Get the Stockscreener App
3.45
0.73%
0.04
Cytek Biosciences Inc stock is traded at $3.45, with a volume of 216.19K.
It is up +0.73% in the last 24 hours and down -16.42% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
See More
Previous Close:
$3.41
Open:
$3.38
24h Volume:
216.19K
Relative Volume:
0.21
Market Cap:
$438.29M
Revenue:
$193.01M
Net Income/Loss:
$-12.15M
P/E Ratio:
-38.33
EPS:
-0.09
Net Cash Flow:
$454.00K
1W Performance:
-16.01%
1M Performance:
-16.42%
6M Performance:
-16.22%
1Y Performance:
-32.11%
1-Day Range:
$3.28
$3.46
1-Week Range:
$3.28
$4.09
52-Week Range:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.445 | 472.00M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
131.61 | 236.51B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
96.70 | 144.75B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
363.25 | 142.80B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
93.39 | 121.80B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.69 | 43.78B | 5.69B | 1.41B | 577.90M | 6.95 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
Cytek Biosciences Inc Stock (CTKB) Latest News
Cytek Biosciences, Inc.'s (NASDAQ:CTKB) latest 13% decline adds to one-year losses, institutional investors may consider drastic measures - simplywall.st
Is Cytek Biosciences Inc. stock ready for a breakout2025 Momentum Check & High Accuracy Investment Signals - newser.com
14,069 Shares in Cytek Biosciences, Inc. $CTKB Bought by Pallas Capital Advisors LLC - Defense World
Long term hold vs stop loss in Cytek Biosciences Inc.Chart Signals & Fast Exit and Entry Trade Guides - newser.com
Using data filters to optimize entry into Cytek Biosciences Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Will Cytek Biosciences Inc. see short term momentumWeekly Investment Report & Reliable Entry Point Alerts - newser.com
Full technical analysis of Cytek Biosciences Inc. stock2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
Should you wait for a breakout in Cytek Biosciences Inc.Insider Selling & Precise Buy Zone Tips - newser.com
Goldman Sachs Group Inc. Reduces Holdings in Cytek Biosciences, Inc. $CTKB - MarketBeat
Leading vs lagging indicators on Cytek Biosciences Inc. performanceIndex Update & AI Enhanced Trading Alerts - newser.com
Aug Chart Watch: What’s next for Pacific Biosciences of California Inc. stockWeekly Investment Summary & Stepwise Trade Signal Guides - خودرو بانک
Trend analysis for Cytek Biosciences Inc. this weekWeekly Trend Summary & Safe Entry Point Alerts - newser.com
Death Cross: Is Cytek Biosciences Inc stock showing strong momentumJuly 2025 Reactions & Free Risk Controlled Daily Trade Plans - خودرو بانک
How to integrate Cytek Biosciences Inc. into portfolio analysis toolsJuly 2025 PostEarnings & AI Based Buy/Sell Signal Reports - newser.com
Volatility clustering patterns for Cytek Biosciences Inc.CEO Change & Precise Entry and Exit Recommendations - newser.com
Will Cytek Biosciences Inc. bounce back from current supportGold Moves & Free AI Powered Buy and Sell Recommendations - newser.com
Published on: 2025-09-18 21:54:33 - newser.com
Analyzing Cytek Biosciences Inc. with risk reward ratio chartsExit Point & Weekly Watchlist for Hot Stocks - newser.com
Caxton Associates LLP Takes $409,000 Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q’s Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control - NewsBreak: Local News & Alerts
Goldman Sachs Group Inc. Sells 183,751 Shares of Cytek Biosciences, Inc. $CTKB - Defense World
Published on: 2025-09-17 01:47:05 - newser.com
Earnings Miss: Is Cytek Biosciences Inc stock showing strong momentumQuarterly Risk Review & Consistent Profit Focused Trading Strategies - خودرو بانک
Market Recap: Is Cytek Biosciences Inc in a long term uptrendTrade Performance Summary & Free Real-Time Volume Trigger Notifications - خودرو بانک
Jacobs Levy Equity Management Inc. Makes New $2.84 Million Investment in Cytek Biosciences, Inc. $CTKB - MarketBeat
Applying chart zones and confluence areas to Cytek Biosciences Inc.July 2025 Pullbacks & Free Safe Capital Growth Stock Tips - newser.com
Aug Drivers: Is Cytek Biosciences Inc stock a good pick for beginnersJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - خودرو بانک
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cytek Biosciences Inc Stock (CTKB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
3.57%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):